Related Experiment Video
Updated: Jul 9, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003
Yu-Peng Wu1,2, Wen-Cai Zheng1,2, Qi Huang1,2
1Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China.
Background:
ND630 is believed to be a new therapy pharmacologic molecule in targeting the expression of ACACA and regulating the lipid metabolism. However, the function of ND630 in prostate cancer remains unknown. KIF18B, as an oncogene, plays a vital role in prostate cancer progression. circKIF18B_003 was derived from oncogene KIF18B and was markedly overexpressed in prostate cancer tissues. We speculated that oncoprotein KIF18B-derived circRNA circKIF18B_003 might have roles in prostate cancer promotion. The aim of this study was to validate whether ND630 could control ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003.
Methods:
RT-qPCR was used to analyze the expression of circKIF18B_003 in prostate cancer cell lines and prostate cancer samples. circKIF18B_003 expression was modulated in prostate cancer cells using circKIF18B_003 interference or overexpression plasmid. We examined the function and effects of circKIF18B_003 in prostate cancer cells using CCK-8, colony formation, wound healing, and Transwell invasion assays and xenograft models. Fluorescence in situ hybridization (FISH) was performed to evaluate the localization of circKIF18B_003. RNA immunoprecipitation (RIP), RNA pull down, and luciferase reporter assay were performed to explore the potential mechanism of circKIF18B_003.
Results:
The function of ND630 was determined in this study. circKIF18B_003 was overexpressed in prostate cancer tissues, and overexpression of circKIF18B_003 was associated with poor survival outcome of prostate cancer patients. The proliferation, migration, and invasion of prostate cancer cells were enhanced after up-regulation of circKIF18B_003. circKIF18B_003 is mainly located in the cytoplasm of prostate cancer cells, and the RIP and RNA pull down assays confirmed that circKIF18B_003 could act as a sponge for miR-370-3p. Further study demonstrated that up-regulation of circKIF18B_003 increased the expression of ACACA by sponging miR-370-3p. The malignant ability of prostate cancer cells enhanced by overexpression of circKIF18B_003 was reversed by the down-regulation of ACACA. We found that overexpression of circKIF18B_003 was associated with lipid metabolism, and a combination of ND-630 and docetaxel markedly attenuated tumor growth.
Conclusion:
ND630 could control ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003. ND630 and circKIF18B_003 may represent a novel target for prostate cancer.
Insights
The drug ND630 regulates lipid metabolism and ACACA expression in prostate cancer by targeting circKIF18B_003. This study reveals circKIF18B_003 as a potential therapeutic target for prostate cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- ND630 is a novel molecule targeting ACACA and lipid metabolism, but its role in prostate cancer is unknown.
- KIF18B is an oncogene crucial for prostate cancer progression, with its derived circRNA, circKIF18B_003, overexpressed in tumors.
- This study investigates ND630's effect on prostate cancer via circKIF18B_003 regulation of ACACA and lipid reprogramming.
Purpose of the Study:
- To determine if ND630 controls ACACA and lipid reprogramming in prostate cancer.
- To investigate the role of circKIF18B_003 in prostate cancer progression.
- To elucidate the regulatory mechanism of ND630 on circKIF18B_003.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) for circKIF18B_003 expression analysis.
- Cellular assays (CCK-8, colony formation, wound healing, Transwell) and xenograft models to assess circKIF18B_003 function.
- RNA immunoprecipitation (RIP), RNA pull down, and luciferase reporter assays to explore molecular mechanisms, including circKIF18B_003 sponging of miR-370-3p.
Main Results:
- circKIF18B_003 overexpression in prostate cancer tissues correlates with poor patient survival.
- Upregulation of circKIF18B_003 enhances prostate cancer cell proliferation, migration, and invasion.
- circKIF18B_003 acts as a sponge for miR-370-3p, increasing ACACA expression and promoting malignant phenotypes; this effect is reversed by ACACA downregulation.
- ND630 combined with docetaxel significantly reduced tumor growth, indicating a role in lipid metabolism regulation.
Conclusions:
- ND630 regulates ACACA and lipid reprogramming in prostate cancer by modulating circKIF18B_003 expression.
- ND630 and circKIF18B_003 represent a promising novel therapeutic target for prostate cancer.
Related Concept Videos
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Negative Regulator Molecules

